High Tower Advisors, LLC I Bio, Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$0.55 - $1.04 $5,737 - $10,849	-10,432 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.06 - $1.52 $2,120 - $3,040	-2,000 Reduced 16.09%	10,432 $11,000
Q2 2021 Aug 06, 2021	BUY	$1.22 - $1.65 $2,440 - $3,300	2,000 Added 19.17%	12,432 $18,000
Q1 2021 May 10, 2021	BUY	$1.18 - $2.62 $354 - $786	300 Added 2.96%	10,432 $15,000
Q4 2020 Feb 10, 2021	SELL	$1.05 - $2.24 $115 - $246	-110 Reduced 1.07%	10,132 $11,000
Q3 2020 Nov 13, 2020	BUY	$1.7 - $6.41 $17,411 - $65,651	10,242 New	10,242 $20,000
Q1 2020 May 21, 2020	SELL	$0.22 - $2.45 $2,200 - $24,504	-10,002 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.57 - $1.05 $1,994 - $3,675	-3,500 Reduced 25.92%	10,002 $8,000
Q2 2018 Aug 14, 2018	BUY	$0.83 - $2.1 $11,206 - $28,354	13,502 New	13,502 $12,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.